Anane Yahia1, Ákos Szlávecz1, Jennifer L Knopp2, Normy Norfiza Abdul Razak3, Asma Abu Samah4, Geoff Shaw2, J Geoffrey Chase2, Balazs Benyo1. 1. Department of Control Engineering and Information Technology, Budapest University of Technology and Economics, Budapest, Hungary. 2. Mechanical Engineering, Centre of Bio-Engineering, University of Canterbury, Christchurch, NZ. 3. Department of Electronics and Communication Engineering, UNITEN, Malaysia. 4. Institute of Energy Infrastructure, Universiti Tenaga Nasional, Jalan Ikram-UNITEN, Kajang, Selangor, Malaysia.
Abstract
BACKGROUND: Critically ill ICU patients frequently experience acute insulin resistance and increased endogenous glucose production, manifesting as stress-induced hyperglycemia and hyperinsulinemia. STAR (Stochastic TARgeted) is a glycemic control protocol, which directly manages inter- and intra- patient variability using model-based insulin sensitivity (SI). The model behind STAR assumes a population constant for endogenous glucose production (EGP), which is not otherwise identifiable. OBJECTIVE: This study analyses the effect of estimating EGP for ICU patients with very low SI (severe insulin resistance) and its impact on identified, model-based insulin sensitivity identification, modeling accuracy, and model-based glycemic clinical control. METHODS: Using clinical data from 717 STAR patients in 3 independent cohorts (Hungary, New Zealand, and Malaysia), insulin sensitivity, time of insulin resistance, and EGP values are analyzed. A method is presented to estimate EGP in the presence of non-physiologically low SI. Performance is assessed via model accuracy. RESULTS: Results show 22%-62% of patients experience 1+ episodes of severe insulin resistance, representing 0.87%-9.00% of hours. Episodes primarily occur in the first 24 h, matching clinical expectations. The Malaysian cohort is most affected. In this subset of hours, constant model-based EGP values can bias identified SI and increase blood glucose (BG) fitting error. Using the EGP estimation method presented in these constrained hours significantly reduced BG fitting errors. CONCLUSIONS: Patients early in ICU stay may have significantly increased EGP. Increasing modeled EGP in model-based glycemic control can improve control accuracy in these hours. The results provide new insight into the frequency and level of significantly increased EGP in critical illness.
BACKGROUND: Critically ill ICU patients frequently experience acute insulin resistance and increased endogenous glucose production, manifesting as stress-induced hyperglycemia and hyperinsulinemia. STAR (Stochastic TARgeted) is a glycemic control protocol, which directly manages inter- and intra- patient variability using model-based insulin sensitivity (SI). The model behind STAR assumes a population constant for endogenous glucose production (EGP), which is not otherwise identifiable. OBJECTIVE: This study analyses the effect of estimating EGP for ICU patients with very low SI (severe insulin resistance) and its impact on identified, model-based insulin sensitivity identification, modeling accuracy, and model-based glycemic clinical control. METHODS: Using clinical data from 717 STAR patients in 3 independent cohorts (Hungary, New Zealand, and Malaysia), insulin sensitivity, time of insulin resistance, and EGP values are analyzed. A method is presented to estimate EGP in the presence of non-physiologically low SI. Performance is assessed via model accuracy. RESULTS: Results show 22%-62% of patients experience 1+ episodes of severe insulin resistance, representing 0.87%-9.00% of hours. Episodes primarily occur in the first 24 h, matching clinical expectations. The Malaysian cohort is most affected. In this subset of hours, constant model-based EGP values can bias identified SI and increase blood glucose (BG) fitting error. Using the EGP estimation method presented in these constrained hours significantly reduced BG fitting errors. CONCLUSIONS: Patients early in ICU stay may have significantly increased EGP. Increasing modeled EGP in model-based glycemic control can improve control accuracy in these hours. The results provide new insight into the frequency and level of significantly increased EGP in critical illness.
Authors: Azurahisham Sah Pri; J Geoffrey Chase; Christopher G Pretty; Geoffrey M Shaw; Jean-Charles Preiser; Jean-Louis Vincent; Mauro Oddo; Fabio S Taccone; Sophie Penning; Thomas Desaive Journal: Crit Care Date: 2014-10-28 Impact factor: 9.097
Authors: L Tappy; M Berger; J M Schwarz; M McCamish; J P Revelly; P Schneiter; E Jéquier; R Chioléro Journal: JPEN J Parenter Enteral Nutr Date: 1999 Sep-Oct Impact factor: 4.016
Authors: Paul D Docherty; J Geoffrey Chase; Thomas Lotz; Christopher E Hann; Geoffrey M Shaw; Juliet E Berkeley; J I Mann; Kirsten McAuley Journal: Open Med Inform J Date: 2009-12-02
Authors: Jessica Lin; Dominic Lee; J Geoffrey Chase; Geoffrey M Shaw; Aaron Le Compte; Thomas Lotz; Jason Wong; Timothy Lonergan; Christopher E Hann Journal: Comput Methods Programs Biomed Date: 2007-06-04 Impact factor: 5.428
Authors: Christopher G Pretty; Aaron J Le Compte; J Geoffrey Chase; Geoffrey M Shaw; Jean-Charles Preiser; Sophie Penning; Thomas Desaive Journal: Ann Intensive Care Date: 2012-06-15 Impact factor: 6.925